Literature DB >> 7492710

Mechanical properties and histological evaluation of sintered beta-Ca2P2O7 with Na4P2O7.10H2O addition.

F H Lin1, C C Lin, C M Lu, H C Liu, J S Sun, C Y Wang.   

Abstract

The ultimate goal of implantation of biomaterials in the skeleton is to reach full integration of the non-living implant with the living bone. The biomaterial can be used much as a bone graft, resorbing or dissolving as bone growth occurs, and the end result is a new remoulded bone. Calcium pyrophosphate, Ca2P2O7, is one of the intermediate products of bone mineralization. beta-Dicalcium pyrophosphate (beta-DCP) doped with certain amounts of Na4P2O7.10H2O was prepared as the developed material. Na4P2O7.10H2O was used as a liquid-phase additive to improve the sintering process and promote physiological bioresorbability. Compressive strength and four-point bending strength were measured by the Bionix test system 858. The mechanical strength of the sintered beta-DCP increased with the addition of Na4P2O7.10H2O up to 5 wt%, but thereafter decreased. The microstructure and crystal structure were analysed by the techniques of SEM, EPMA, TEM and XRD. The relationship between the mechanical strength of the sintered bioceramics and the Na4P2O7.10H2O dopant was examined in terms of the presence of NaCa(PO3)3, grain growth and abnormal grain coalescence while the dopant increased. Preliminary in vivo evaluation was studied by rabbit femur condyle implantation. There was no inflammation or any toxic sign during the experimental period. The histological section of intraosseous implantation revealed that the new bone deposited directly on the surface of the material in the fourth week after operation. The implant gradually decreased in volume and was replaced by the surrounding regenerated bone in the rabbit condyle in vivo environment. The results led us to conclude that the developed material has great potential as a biodegradable bone substitute.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492710     DOI: 10.1016/0142-9612(95)99642-y

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Bioceramics Based on β-Calcium Pyrophosphate.

Authors:  Tatiana Safronova; Andrey Kiselev; Irina Selezneva; Tatiana Shatalova; Yulia Lukina; Yaroslav Filippov; Otabek Toshev; Snezhana Tikhonova; Olga Antonova; Alexander Knotko
Journal:  Materials (Basel)       Date:  2022-04-25       Impact factor: 3.748

2.  Biodegradation behavior and cytotoxicity of the composite membrane composed of beta-dicalcium pyrophosphate and glucose mediated (polyethylene glycol/chitosan).

Authors:  Jian Wen Wang; Min Hsiung Hon
Journal:  J Mater Sci Mater Med       Date:  2004-02       Impact factor: 3.896

3.  The first clinical trial of beta-calcium pyrophosphate as a novel bone graft extender in instrumented posterolateral lumbar fusion.

Authors:  Jae Hyup Lee; Bong-Soon Chang; Ul-Oh Jeung; Kun-Woo Park; Min-Seok Kim; Choon-Ki Lee
Journal:  Clin Orthop Surg       Date:  2011-08-19

4.  Pyrophosphate Stimulates Differentiation, Matrix Gene Expression and Alkaline Phosphatase Activity in Osteoblasts.

Authors:  Michael Pujari-Palmer; Shiuli Pujari-Palmer; Xi Lu; Thomas Lind; Håkan Melhus; Thomas Engstrand; Marjam Karlsson-Ott; Hakan Engqvist
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

5.  Effects of BMP-2 Delivery in Calcium Phosphate Bone Graft Materials with Different Compositions on Bone Regeneration.

Authors:  Jin-Chul Park; Eun-Bin Bae; Se-Eun Kim; So-Yun Kim; Kyung-Hee Choi; Jae-Won Choi; Ji-Hyeon Bae; Jae-Jun Ryu; Jung-Bo Huh
Journal:  Materials (Basel)       Date:  2016-11-23       Impact factor: 3.623

6.  Bone without borders - Monetite-based calcium phosphate guides bone formation beyond the skeletal envelope.

Authors:  Furqan A Shah; Martina Jolic; Chiara Micheletti; Omar Omar; Birgitta Norlindh; Lena Emanuelsson; Håkan Engqvist; Thomas Engstrand; Anders Palmquist; Peter Thomsen
Journal:  Bioact Mater       Date:  2022-04-06

7.  Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.

Authors:  Yi-Jie Kuo; Fon-Yih Tsuang; Jui-Sheng Sun; Chi-Hung Lin; Chia-Hsien Chen; Jia-Ying Li; Yi-Chian Huang; Wei-Yu Chen; Chin-Bin Yeh; Jia-Fwu Shyu
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

8.  Long-Term Oral Toxicity and Anti-osteoporotic Effect of Sintered Dicalcium Pyrophosphate in Rat Model of Postmenopausal Osteoporosis.

Authors:  Yuh-Feng Tsai; Li-Ho Hsu; Chang-Chin Wu; Wei-Hua Cai; Kai-Chiang Yang; Fang-Yu Fan
Journal:  J Med Biol Eng       Date:  2017-01-03       Impact factor: 1.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.